Lowenstein Sandler represented mParticle, while Davis Polk & Wardwell advised Rokt on the deal. Rokt, the global leader in e-commerce, announced its $300 million merger with...
Rokt’s $300 Million Merger with mParticle
Johnson & Johnson’s Acquisition of Intra-Cellular Therapies
Cravath is representing Johnson & Johnson, Davis Polk & Wardwell is serving as legal advisor to Intra-Cellular Therapies, and Skadden is representing Centerview Partners LLC and...
Johnson & Johnson’s Acquisition of Intra-Cellular Therapies
Cravath is representing Johnson & Johnson, Davis Polk & Wardwell is serving as legal advisor to Intra-Cellular Therapies, and Skadden is representing Centerview Partners LLC and...
Aebi Schmidt Group’s Merger With The Shyft Group
On the deal, Bär & Karrer and Wuersch & Gering advised Aebi Schmidt; Davis Polk & Wardwell and Lenz & Staehelin acted for The Shyft Group;...
Windstream Holdings’ Merger with Uniti Group
Debevoise & Plimpton is advising Windstream Holdings on the transaction, and Davis Polk & Wardwell is advising Uniti Group Inc. Windstream Holdings (“Windstream”) announced its merger...
Advent International’s $6.3 Billion Acquisition of Nuvei
Kirkland & Ellis and Blake, Cassels & Graydon are advising Advent International on the transaction, Stikeman Elliott and Davis Polk & Wardwell are advising Nuvei Corporation,...
General Atlantic and Stone Point Capital’s $1.65 Billion Acquisition of HireRight
Paul, Weiss, Rifkind, Wharton & Garrison is advising General Atlantic Service Company, L.P. and Stone Point Capital on the transaction, Simpson Thacher & Bartlett is advising...
GSK’s Licensing Agreement with Hansoh Pharma for HS-20093
Davis Polk & Wardwell advised GSK on the transaction. GSK plc (LSE/NYSE: GSK) and Hansoh Pharma (HKEX: 03692) announced that they have entered into an exclusive license...
Yieldstreet’s Acquisition of Cadre
Davis Polk & Wardwell is advising Cadre on the transaction. Yieldstreet announced it entered a definitive agreement to acquire Cadre. The transaction is subject to regulatory review. Financial...
Smith+Nephew’s $330 Million Acquisition of CartiHeal
Davis Polk & Wardwell is advising Smith+Nephew on the transaction. Smith+Nephew (NYSE:SNN) announced it has entered into a definitive agreement of CartiHeal. Under the terms of the...
GSK’s Licensing Agreement with Hansoh Pharma
Davis Polk & Wardwell advised GSK on the deal. GSK plc (LSE/NYSE: GSK) and Hansoh Pharma (HKEX: 03692) announced that they have entered into an exclusive license...
PracticeTek’s Merger with Integrated Practice Solutions
Davis Polk & Wardwell advised PracticeTek and Lightyear; and Greenberg Traurig advised PracticeTek on the transaction. Kirkland & Ellis LLP acted as legal advisor to IPS...